Cedars-Sinai Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Cedars-Sinai Medical Center sits in the top decile of US sponsors by registered trial count (#106 of 15,742 sponsors by registered trial count).
Cedars-Sinai Medical Center: 339 sponsored US clinical trials, 70 recruiting.
Cedars-Sinai Medical Center sponsors 339 registered US clinical trials on ClinicalTrials.gov, 70 of them currently recruiting, and 180 completed. 42 of these trials are in Phase 3-4 (later-stage) and 83 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bladder Cancer, with 6 trials.
Top-decile sponsor footprint
Cedars-Sinai Medical Center ranks in the top decile of sponsors by registered trial count (#106 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
180 of 230 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
339 total, page 6 of 7
Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer
NCT01908478
Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy
NCT02147639
Sodium Nitrate to Improve Blood Flow
NCT02847975
Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery
NCT01976988
Use of FlexHD as Post Trapeziectomy Spacer
NCT01998594
Efficacy of Popliteal Nerve Blocks With and Without Dexamethasone on the Duration of Analgesia for Foot & Ankle Surgery
NCT01975285
Pilot of AbStats /AEGIS System for Detecting Motility Abnormalities
NCT02233270
Stoma Tube Decompression and Postoperative Ileus After Major Colorectal Surgery
NCT01911793
Effects of Hookah Smoking on Blood Flow to the Heart, Muscle and Skin
NCT02147665
Surgical Indirect Revascularization For Symptomatic Intracranial Arterial Stenosis
NCT01819597
Dexmedetomidine for Reversal of Cocaine's Effects on the Heart
NCT01927640
The Effects of Ketamine and Methadone on Postoperative Pain for Laminectomy
NCT02252432
Improving Pancreas Radiotherapy Plans Using Respiration-driven Anatomic Deformation: A Pilot Study
NCT02024997
Preoperative Anxiety Evaluation: a New Visual Smileys Scale
NCT02667847
Optimal Duration of Indwelling Urinary Catheter Following Pelvic Surgery
NCT01923129
The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation
NCT02013037
Prospective Controlled Trial On Clear Feeds Versus Low Residue Diet After Surgery In Elective Colorectal Surgery Patients
NCT01890499
A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation
NCT01594424
Syngo NATIVE Contrast Enhanced 3D MRA on 3T Verio Magnet
NCT02065648
Identification of Adverse Plaque Characteristics by Coronary MR Angiography
NCT01986868
Role of Methane in Glycemic Control
NCT01638429
Acromegaly Combination Treatment Study
NCT01538966
Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases
NCT02279992
PDE Inhibitors in DMD Study (Acute Dosing Study)
NCT01580501
Is Treatment of Vitamin D Deficiency Associated With Resolution of Statin-Induced Muscular Symptoms
NCT01568255
Study: Study to Compare Video Miller Device to Direct Laryngoscopy
NCT01371032
Effect of Fentanyl on Coughing and Recovery After Anesthesia With an LMA Laryngeal Mask Airway)for Airway Management
NCT01368809
Esmolol Infusion During Laminectomy: Effect on Quality of Recovery
NCT01179113
Tadalafil and Sildenafil for Duchenne Muscular Dystrophy
NCT01359670
Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
NCT01342029
Effect of Ketamine on Postoperative Clinical Outcomes
NCT01365195
Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla)
NCT02092428
Cardiac Autonomic Function in Women with Microvascular Coronary Dysfunction
NCT01568177
Tissue Biomarker for Pegvisomant Action
NCT01261000
The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma
NCT01235793
Masimo Radical-7 Monitor a Useful Adjuvant During Major Spine Surgery
NCT01221961
Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery
NCT01559675
Effect of Sugared Chewing Gum on Gastrointestinal Recovery After Major Colorectal Surgery
NCT01559662
Early Propranolol After Traumatic Brain Injury: Phase II
NCT01202110
Comparative Effectiveness of Intubating Devices in the Morbidly Obese
NCT01114945
Effect of Lidocaine and Esmolol to Improve the Quality of Recovery
NCT01114997
Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS)
NCT01085643
Tadalafil in Becker Muscular Dystrophy
NCT01070511
Intubation of Patients With an Unstable Cervical Spine Using the CMAC Device
NCT01113723
Dendritic Cell Vaccine With Imiquimod for Patients With Malignant Glioma
NCT01792505
Labetalol and Esmolol: Vital Signs and Post Operative Pain Management
NCT01114971
The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
NCT00973557
Cut Your Pressure Too: The Altadena Barbershop Blood Pressure Study, Phase 2 (Intervention Pilot Study)
NCT02198144
Medical Review: Hand Surgery After Local Block Versus Non-block
NCT01110759
Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
NCT00939523
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 43 |
| Phase 2 | 40 |
| Phase 3 | 9 |
| Phase 4 | 33 |
What is open in the Cedars-Sinai Medical Center pipeline
70 recruiting of 339 indexed (21% open); 180 completed (53%).
Phase mix: 42 late (III/IV) vs 83 early (I/II) (early-phase heavy).
Top condition: Bladder Cancer (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Cedars-Sinai Medical Center: open-pipeline peers nationwide
Peers matched on 339 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
Cedars-Sinai Medical Center sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 339 trials (± recruiting share)
- National Institutes of Health Clinical Center (CC) · 338 trials · 7% recruiting
- Ohio State University Comprehensive Cancer Center · 341 trials · 23% recruiting
- Children's Oncology Group · 342 trials · 10% recruiting
- National Institute of Mental Health (NIMH) · 343 trials · 12% recruiting
Sponsors near 21% open enrollment (± trial volume)
- University of Colorado, Denver · 21% recruiting · 1,283 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this Cedars-Sinai Medical Center page
339 registered trials is a research-attention snapshot, not an endorsement of Cedars-Sinai Medical Center or any single study.
- 70 of Cedars-Sinai Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bladder Cancer is the condition Cedars-Sinai Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bladder Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Cedars-Sinai Medical Center pipeline card: 339 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.